Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

Incyte Aktie News & Pressemeldungen

Incyte Eulerpool News

11/19/2024, 11:08:59 PM

Incyte stoppt Patientenaufnahme in wesentlicher Studie: Aktienkurs fällt drastisch

11/19/2024, 6:37:13 PM

Incyte: Herausforderungen und Chancen im biopharmazeutischen Sektor

11/16/2024, 11:46:49 AM

FDA erteilt Syndax grünes Licht für innovatives Leukämiemedikament

2/6/2024, 6:26:31 PM

Novartis setzt auf Krebsmedikament Pelabresib und erwirbt Morphosys für 2,7 Milliarden Euro

2/6/2024, 12:48:27 PM

Novartis erwirbt Biotech-Perle Morphosys für 2,7 Milliarden Euro

1

2

1

2

Incyte Stock News

Incyte is being monitored by journalists and investors worldwide. We gather the latest Incyte news here.

December 17 ·
Yahoo
Incyte to Present at Upcoming Investor Conference
December 12 ·
MarketWatch
Incyte Corp. stock outperforms competitors despite losses on the day
December 12 ·
SeekingAlpha
Tracking Baker Brothers Portfolio - Q3 2024 Update
December 11 ·
Yahoo
Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More
December 10 ·
MarketWatch
Incyte Corp. stock outperforms competitors on strong trading day
December 10 ·
Yahoo
Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma
December 9 ·
Yahoo
Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals
December 9 ·
MarketWatch
Incyte Corp. stock underperforms Monday when compared to competitors
December 9 ·
Yahoo
EXEL or INCY: Which Is the Better Value Stock Right Now?
December 7 ·
Yahoo
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer

1

2

1

2

Incyte Stock Press Releases

Incyte regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2